The paper “Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata” was published in the Journal of Antibiotics. The first author of the paper is Misao Takemoto (formerly Yoneyama), a former student of our lab who completed the PhD program. This paper has screened a natural product library to identify novel small molecule […]
The paper “DSIF and NELF interact with Integrator to specify the correct post-transcriptional fate of snRNA genes” has been published in Nature Communications (Nature’s sister journal). The first author of the paper is Junichi Yamamoto, a post-doctoral researcher in our lab. The discovery of the mechanism by which NELF directly interacts with RNA polymerase II,
With support from the KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas “Transcription Cycle,” we are pleased to invite Professor Cheng-Ming Chiang (UT Southwestern Medical Center at Dallas) to our university to hold a seminar on Friday, December 6 from 16:30 to 18:00 at B2 Building 226 Lecture Room The seminar was entitled “Epigenetic Control
PhD student Vipul Gupta’s paper “Salicylic acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity was accepted for publication in Molecular Pharmacology and is posted on the website as a preliminary electronic version. In this paper, we discovered a new intracellular target protein of salicylic acid (acetylsalicylic acid = precursor of aspirin), an antipyretic
PhD student Satoki Karasawa’s paper “Vitamin K2 covalently binds to Bak and induces Bak-mediated apoptosis” has been accepted for publication in Molecular Pharmacology Molecular Pharmacology and a preliminary version has been published online. Please click here for more details.
A new review article on gene expression regulation has been published in BBA. Please click here for details.
A new paper, “Identification of DNA-dependent protein kinase catalytic subunits (DNA-PKcs) as a novel target of Bisphenol A DNA-PKcs as a novel target of Bisphenol A” has been published in PLoS ONE. This paper identifies a novel intracellular target factor for Bisphenol A, a compound considered an endocrine disruptor. For more information, please see the
